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Type 2 diabetes mellitus is recognized as a significant risk factor for fragility of bone.
Among the newer anti-diabetic agents, dipeptidyl peptidase-4 inhibitors (DPP4i) have
been reported to decrease the occurrence of bone fractures although the reason is
unclear. The main aim of this study was to evaluate the impact of sitagliptin
treatment on tissue bone strength and compositional parameters in the high-fat-fed
mouse model. Male NIH swiss mice were allowed free access to high-fat diet for
150 days to induce chronic hyperglycemia and insulin resistance. Sitagliptin was
administered once daily for 3 weeks. High-fat-fed mice administered with saline were
used as controls. Bone strength was assessed at the organ and tissue level by three-
point bending and nanoindentation, respectively. Bone microarchitecture was
investigated by microcomputed tomography and bone composition was evaluated by
Fourier transform infrared imaging and quantitative backscattered electron imaging.
Administration of sitagliptin increased non-fasting insulin, improved glucose
tolerance and increased insulin sensitivity. This was associated with clear
ameliorations in bone strength at the organ and tissue level. No changes in trabecular
or cortical microarchitectures were observed. On the other hand, higher values of Ca,
Ca, collagen maturity, mineral/matrix ratio, mineral maturity and crystal size index
were evidenced after sitagliptin treatment. Correlation analysis significantly linked
the modifications of bone strength to changes in bone compositional parameters.
These results bring new light on the mode of action of sitagliptin on bone physiology
and demonstrate a benefit of DPP4i.
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